Biomatics Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 2

Professionals

  • Investments
  • 31

  • Portfolio
  • 8

  • Exits
  • 13

Exits

Biomatics Capital General Information

Company Description

Founded in 2016, Biomatics Capital is a venture capital investment firm based in Seattle, Washington. The firm seeks to invest in companies operating in the healthcare, technology and life science sectors. This firm is a Registered Investment Adviser (RIA).

Business Details

Year Founded
2016
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 188 East Blaine Street
  • Suite 126
  • Seattle, WA 98102
  • United States
+1 (206)

Biomatics Capital Investments (31)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Neumora 11-Oct-2022 Early Stage VC Drug Discovery Generating Revenue/Not Profitable
Encodia 24-Jan-2021 Biotechnology Generating Revenue
Verve Therapeutics 14-Jan-2021 Drug Discovery Generating Revenue/Not Profitable
Thrive Earlier Detection 24-Jul-2020 Biotechnology Generating Revenue
Compass Therapeutics 19-Jun-2020 Drug Discovery Generating Revenue/Not Profitable
Verve Therapeutics 11-Jun-2020 Drug Discovery Generating Revenue/Not Profitable
Guide Therapeutics 13-Jan-2020 Drug Delivery Generating Revenue
Omniome 10-Jan-2020 Biotechnology Generating Revenue
AiCure 07-Nov-2019 Later Stage VC Outcome Management (Healthcare) Generating Revenue
Egenesis 01-Nov-2019 Early Stage VC Biotechnology Pre-Clinical Trials
You’re viewing 10 of 31 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomatics Capital Exits (13)

Company Name Exit Date Exit Type Exit Size
Verve Therapeutics 29-Nov-2023 Public Investment 2nd Offering
Neumora 15-Sep-2023
Compass Therapeutics 04-Nov-2021
Blackthorn Therapeutics 07-Oct-2021
Alairion 01-Oct-2021
Omniome 20-Sep-2021
GRAIL 18-Aug-2021
Verve Therapeutics 17-Jun-2021
Guide Therapeutics 23-Feb-2021 Merger/Acquisition
Thrive Earlier Detection 05-Jan-2021 Merger/Acquisition
You’re viewing 10 of 13 exits. Get the full list »

Biomatics Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Biomatics Capital Co-Investors (31)

Name With Exits Lead Partner Series Industry
ARCH Venture Partners 2 Series chart Industry bar
GV Series chart Industry bar
Altitude Life Science Ventures Series chart Industry bar
Citadel Enterprise Americas Series chart Industry bar
The Invus Group Series chart Industry bar
You’re viewing 5 of 31 co-investors. Get the full list »

Biomatics Capital FAQs

  • What is Biomatics Capital?

    Founded in 2016, Biomatics Capital is a venture capital investment firm based in Seattle, Washington.

  • When was Biomatics Capital founded?

    Biomatics Capital was founded in 2016.

  • Where is Biomatics Capital headquartered?

    Biomatics Capital is headquartered in Seattle, WA.

  • What is Biomatics Capital's total asset value?

    Biomatics Capital has around in total assets under management.

  • How many investments has Biomatics Capital made?

    Biomatics Capital has made 31 investments.

  • What has Biomatics Capital invested in?

    Biomatics Capital has made numerous investments in companies like Neumora, Encodia, and Verve Therapeutics within the Drug Discovery and Biotechnology industries.

  • What has Biomatics Capital invested in recently?

    Biomatics Capital's latest investment was on 11-Oct-2022 in Neumora, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »